Milestone Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Milestone Asset Management's ARKG Position: Q3 2026 in Review
Milestone Asset Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 18% in Q3 2026, selling an estimated $45K and leaving 4,585 shares worth $249K. The position accounts for 0.04% of the portfolio, ranked #216.
Milestone Asset Management first reported a position in ARKG in Q2 2026 and has held it in 2 quarters since. 316 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- Milestone Asset Management held 4,585 shares of ARK Genomic Revolution ETF worth $249K as of Q3 2026.
- Milestone Asset Management sold 1,000 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $45K.
- ARK Genomic Revolution ETF made up 0.04% of Milestone Asset Management's portfolio in Q3 2026, its #216 holding.
- Milestone Asset Management first reported a position in ARK Genomic Revolution ETF in Q2 2026 and has held it in 2 quarters since.
- 316 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on Milestone Asset Management's 13F filing for Q3 2026, filed 15 Oct 2026.